CLINICAL STUDY: CARDIOVASCULAR IMAGING
Echocardiographic detection of early diabetic myocardial disease
Zhi You Fang, BM, MHSc*,
Satoshi Yuda, MD, PhD*,
Vinah Anderson, BSN*,
Leanne Short, BS*,
Colin Case, MSc* and
Thomas H. Marwick, MB.BS, PhD, FACC*,*
* University of Queensland, Brisbane, Australia
Manuscript received April 26, 2002;
revised manuscript received August 26, 2002,
accepted November 1, 2002.
* Reprint requests and correspondence: Prof. Thomas H. Marwick, University of Queensland Department of Medicine, Princess Alexandra Hospital, Ipswich Road, Brisbane, Qld 4012, Australia. tmarwick{at}medicine.pa.uq.edu.au
OBJECTIVES: We sought to determine whether disturbances of myocardial contractility and reflectivity could be detected in diabetic patients without overt heart disease and whether these changes were independent and incremental to left ventricular hypertrophy (LVH).
BACKGROUND: Left ventricular (LV) dysfunction is associated with diabetes mellitus, but LVH is common in this population and the relationship between diabetic LV dysfunction and LVH is unclear.
METHODS: We studied 186 patients with normal ejection fraction and no evidence of CAD: 48 with diabetes mellitus only (DM group), 45 with LVH only (LVH group), 45 with both diabetes and LVH (DH group), and 48 normal controls. Peak strain and strain rate of six walls in apical four-chamber, long-axis, and two-chamber views were evaluated and averaged for each patient. Calibrated integrated backscatter (IB) was assessed by comparison of the septal or posterior wall with pericardial IB intensity.
RESULTS: All patient groups (DM, DH, LVH) showed reduced systolic function compared with controls, evidenced by lower peak strain (p < 0.001) and strain rate (p = 0.005). Calibrated IB, signifying myocardial reflectivity, was greater in each patient group than in controls (p < 0.05). Peak strain and strain rate were significantly lower in the DH group than in those in the DM alone (p < 0.03) or LVH alone (p = 0.01) groups.
CONCLUSIONS: Diabetic patients without overt heart disease demonstrate evidence of systolic dysfunction and increased myocardial reflectivity. Although these changes are similar to those caused by LVH, they are independent and incremental to the effects of LVH.
|
Abbreviations and Acronyms
| | Am | | peak myocardial late diastolic velocity | | ANOVA | | analysis of variance | | CAD | | coronary artery disease | | DH group | | diabetic patients with left ventricular hypertrophy | | DM group | | diabetic patients without left ventricular hypertrophy | | Em | | peak myocardial early diastolic velocity | | HbA1c | | hemoglobin A1c | | IB | | integrated backscatter | | LV | | left ventricular | | LVH | | left ventricular hypertrophy | | LVH group | | nondiabetic patients with left ventricular hypertrophy |
|
This article has been cited by other articles:

|
 |

|
 |
 
J. M. Nielsen, S. B. Kristiansen, R. Norregaard, C. L. Andersen, L. Denner, T. T. Nielsen, A. Flyvbjerg, and H. E. Botker
Blockage of receptor for advanced glycation end products prevents development of cardiac dysfunction in db/db type 2 diabetic mice
Eur J Heart Fail,
July 1, 2009;
11(7):
638 - 647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Stefanidis, S. Bousboulas, J. Kalafatis, K. Baroutsi, P. Margos, K. Komninos, S. Pappas, and E. Papasteriadis
Left ventricular anatomical and functional changes with ageing in type 2 diabetic adults
Eur J Echocardiogr,
July 1, 2009;
10(5):
647 - 653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. H. Marwick, M. D. Hordern, T. Miller, D. A. Chyun, A. G. Bertoni, R. S. Blumenthal, G. Philippides, A. Rocchini, and on behalf of the American Heart Association Exerci
Exercise Training for Type 2 Diabetes Mellitus: Impact on Cardiovascular Risk: A Scientific Statement From the American Heart Association
Circulation,
June 30, 2009;
119(25):
3244 - 3262.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Gul, A. S. Celebi, F. Kacmaz, O. C. Ozcan, I. Ustun, D. Berker, Y. Aydin, T. Delibasi, S. Guler, and A. O. Barazi
The tissue-Doppler imaging must be performed to detect early left ventricle dysfunction in patients with type 1 diabetes mellitus
Eur J Echocardiogr,
June 18, 2009;
(2009)
jep086v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Verhaert and J. D. Thomas
Dysglycemia and acute myocardial infarction the role of echocardiography.
J. Am. Coll. Cardiol. Img.,
May 1, 2009;
2(5):
600 - 603.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Mogelvang, P. Sogaard, S. A. Pedersen, N. T. Olsen, P. Schnohr, and J. S. Jensen
Tissue Doppler echocardiography in persons with hypertension, diabetes, or ischaemic heart disease: the Copenhagen City Heart Study
Eur. Heart J.,
March 2, 2009;
30(6):
731 - 739.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kamalesh
Diabetes and prognosis: are systolic and diastolic heart failure different?
Heart,
February 1, 2009;
95(3):
178 - 179.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Kellogg, K. Converso, T. Wiggin, M. Stevens, and R. Pop-Busui
Effects of cyclooxygenase-2 gene inactivation on cardiac autonomic and left ventricular function in experimental diabetes
Am J Physiol Heart Circ Physiol,
February 1, 2009;
296(2):
H453 - H461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Schneider, R. Malisius, K. Krause, F. Lampe, E. Bahlmann, S. Boczor, M. Antz, S. Ernst, and K.-H. Kuck
Strain rate imaging for functional quantification of the left atrium: atrial deformation predicts the maintenance of sinus rhythm after catheter ablation of atrial fibrillation
Eur. Heart J.,
June 1, 2008;
29(11):
1397 - 1409.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Dal-Bianco, A. S. Jaffe, M. R. Bell, and J. K. Oh
Cardiac Function and Brain-Type Natriuretic Peptide in First-Time Flash Pulmonary Edema
Mayo Clin. Proc.,
March 1, 2008;
83(3):
289 - 296.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Siegmund, P.-M. Schumm-Draeger, D. Antoni, and H. Von Bibra
Beneficial effects of ramipril on myocardial diastolic function in patients with type 2 diabetes mellitus, normal LV systolic function and without coronary artery disease: a prospective study using tissue Doppler
Diabetes and Vascular Disease Research,
December 1, 2007;
4(4):
358 - 364.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ganame, L. Mertens, B. W. Eidem, P. Claus, J. D'hooge, L. M. Havemann, C. J. McMahon, M. A. A. Elayda, W. K. Vaughn, J. A. Towbin, et al.
Regional myocardial deformation in children with hypertrophic cardiomyopathy: morphological and clinical correlations
Eur. Heart J.,
December 1, 2007;
28(23):
2886 - 2894.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Donal, M. Roulaud, P. Raud-Raynier, C. De Bisschop, C. Leclercq, G. Derumeaux, J.-C. Daubert, P. Mabo, and A. Denjean
Echocardiographic right ventricular strain analysis in chronic heart failure
Eur J Echocardiogr,
December 1, 2007;
8(6):
449 - 456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-W. Ha, H.-C. Lee, E.-S. Kang, C.-M. Ahn, J.-M. Kim, J.-A. Ahn, S.-W. Lee, E.-Y. Choi, S.-J. Rim, J. K Oh, et al.
Abnormal left ventricular longitudinal functional reserve in patients with diabetes mellitus: implication for detecting subclinical myocardial dysfunction using exercise tissue Doppler echocardiography
Heart,
December 1, 2007;
93(12):
1571 - 1576.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.A. Connelly, D.J. Kelly, Y. Zhang, D.L. Prior, J. Martin, A.J. Cox, K. Thai, M.P. Feneley, J. Tsoporis, K.E. White, et al.
Functional, structural and molecular aspects of diastolic heart failure in the diabetic (mRen-2)27 rat
Cardiovasc Res,
November 1, 2007;
76(2):
280 - 291.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Steine, J. R. Larsen, M. Stugaard, T. J. Berg, M. Brekke, and K. Dahl-Jorgensen
LV systolic impairment in patients with asymptomatic coronary heart disease and type 1 diabetes is related to coronary atherosclerosis, glycaemic control and advanced glycation endproducts
Eur J Heart Fail,
October 1, 2007;
9(10):
1044 - 1050.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Yue, T. Arai, M. Terashima, A. Y. Sheikh, F. Cao, D. Charo, G. Hoyt, R. C. Robbins, E. A. Ashley, J. Wu, et al.
Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse
Am J Physiol Heart Circ Physiol,
May 1, 2007;
292(5):
H2106 - H2118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Okuda, T. Ito, N. Emura, M. Suwa, T. Hayashi, H. Yoneda, and Y. Kitaura
Depressed Myocardial Contractile Reserve in Patients With Obstructive Sleep Apnea Assessed by Tissue Doppler Imaging With Dobutamine Stress Echocardiography
Chest,
April 1, 2007;
131(4):
1082 - 1089.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Avgeropoulou, A. Illmann, P.-M. Schumm-Draeger, J. Kallikazaros, and H. Von Bibra
Assessment of arterio-ventricular coupling by tissue Doppler and wave intensity in type 2 diabetes
The British Journal of Diabetes & Vascular Disease,
November 1, 2006;
6(6):
271 - 278.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Loimaala, K. Groundstroem, S. Majahalme, A. Nenonen, and I. Vuori
Impaired myocardial function in newly onset Type 2 diabetes associates with arterial stiffness
Eur J Echocardiogr,
October 1, 2006;
7(5):
341 - 347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Moir, L Hanekom, Z-Y Fang, B Haluska, C Wong, M Burgess, and T H Marwick
Relationship between myocardial perfusion and dysfunction in diabetic cardiomyopathy: a study of quantitative contrast echocardiography and strain rate imaging
Heart,
October 1, 2006;
92(10):
1414 - 1419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sulfi and A. D Timmis
Review: Heart failure complicating acute myocardial infarction in patients with diabetes: pathophysiology and management strategies
The British Journal of Diabetes & Vascular Disease,
September 1, 2006;
6(5):
191 - 196.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chung, P. Abraszewski, X. Yu, W. Liu, A. J. Krainik, M. Ashford, S. D. Caruthers, J. B. McGill, and S. A. Wickline
Paradoxical Increase in Ventricular Torsion and Systolic Torsion Rate in Type I Diabetic Patients Under Tight Glycemic Control
J. Am. Coll. Cardiol.,
January 17, 2006;
47(2):
384 - 390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Stowasser, J. Sharman, R. Leano, R. D. Gordon, G. Ward, D. Cowley, and T. H. Marwick
Evidence for Abnormal Left Ventricular Structure and Function in Normotensive Individuals with Familial Hyperaldosteronism Type I
J. Clin. Endocrinol. Metab.,
September 1, 2005;
90(9):
5070 - 5076.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Y. Fang, J. Sharman, J. B. Prins, and T. H. Marwick
Determinants of Exercise Capacity in Patients With Type 2 Diabetes
Diabetes Care,
July 1, 2005;
28(7):
1643 - 1648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. A. Parsonage and D. B. Ojji
Getting to the heart of obesity
Eur. Heart J.,
June 2, 2005;
26(12):
1150 - 1151.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Pop-Busui, I. Kirkwood, H. Schmid, V. Marinescu, J. Schroeder, D. Larkin, E. Yamada, D. M. Raffel, and M. J. Stevens
Sympathetic dysfunction in type 1 diabetes: Association with impaired myocardial blood flow reserve and diastolic dysfunction
J. Am. Coll. Cardiol.,
December 21, 2004;
44(12):
2368 - 2374.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Mottram, B. Haluska, R. Leano, D. Cowley, M. Stowasser, and T. H. Marwick
Effect of Aldosterone Antagonism on Myocardial Dysfunction in Hypertensive Patients With Diastolic Heart Failure
Circulation,
August 3, 2004;
110(5):
558 - 565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Y. Fang, J. B. Prins, and T. H. Marwick
Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications
Endocr. Rev.,
August 1, 2004;
25(4):
543 - 567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. H. Young
Diastolic Function and Type 1 Diabetes
Diabetes Care,
August 1, 2004;
27(8):
2081 - 2083.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. F. Johnson, R. W. Nesto, M. A. Pfeifer, W. R. Slater, A. I. Vinik, D. A. Chyun, G. Law, F. J.Th. Wackers, and L. H. Young
Cardiac Abnormalities in Diabetic Patients With Neuropathy: Effects of aldose reductase inhibitor administration
Diabetes Care,
February 1, 2004;
27(2):
448 - 454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Weyman
The year in echocardiography
J. Am. Coll. Cardiol.,
January 7, 2004;
43(1):
140 - 148.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Nesto, D. Bell, R. O. Bonow, V. Fonseca, S. M. Grundy, E. S. Horton, M. Le Winter, D. Porte, C. F. Semenkovich, S. Smith, et al.
Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure: A consensus statement from the American Heart Association and American Diabetes Association
Diabetes Care,
January 1, 2004;
27(1):
256 - 263.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, B. H. Greenberg, J. D. Knoke, K. U. Knowlton, W. Y. W. Lew, and S. Tsimikas
Highlights of the year in JACC 2003
J. Am. Coll. Cardiol.,
December 17, 2003;
42(12):
2156 - 2166.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Nesto, D. Bell, R. O. Bonow, V. Fonseca, S. M. Grundy, E. S. Horton, M. Le Winter, D. Porte, C. F. Semenkovich, S. Smith, et al.
Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure: A Consensus Statement From the American Heart Association and American Diabetes Association
Circulation,
December 9, 2003;
108(23):
2941 - 2948.
[Full Text]
[PDF]
|
 |
|
|